-transparent.png){kind=logo}
The effect of chronic haloperidol on brain beta-endorphin immunoreactivity was examined in rats. Chronic haloperidol resulted in significant reductions of beta-endorphin immunoreactivity within the striatum, but other brain regions were uneffected. When a variety of neuroleptic drugs were tested, fluphenazine, chlorpromazine and haloperidol resulted in comparable reductions in beta-endorphin immunoreactivity in the striatum. These findings suggest a functional interaction between beta-endorphin and dopamine systems in the striatum.
Related Publications
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
June 1984,
Neuroscience letters,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
December 1981,
Brain research bulletin,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
September 1978,
Life sciences,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
August 1982,
Brain research,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
March 1985,
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
November 1984,
Methods and findings in experimental and clinical pharmacology,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
October 1977,
Science (New York, N.Y.),
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
January 1980,
Advances in biochemical psychopharmacology,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
August 1982,
The Journal of clinical endocrinology and metabolism,
M F Beal, and
J Fisher, and
D B Carr, and
J B Martin
December 1982,
Anesthesiology,
